nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.131	0.22	CbGbCtD
Fosphenytoin—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.099	0.167	CbGbCtD
Fosphenytoin—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0691	0.116	CbGbCtD
Fosphenytoin—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.056	0.0943	CbGbCtD
Fosphenytoin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0432	0.0727	CbGbCtD
Fosphenytoin—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0417	0.0702	CbGbCtD
Fosphenytoin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0402	0.0676	CbGbCtD
Fosphenytoin—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0375	0.0632	CbGbCtD
Fosphenytoin—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0296	0.0498	CbGbCtD
Fosphenytoin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0184	0.0311	CbGbCtD
Fosphenytoin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0169	0.0285	CbGbCtD
Fosphenytoin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0115	0.0194	CbGbCtD
Fosphenytoin—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00023	0.000566	CcSEcCtD
Fosphenytoin—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000566	CcSEcCtD
Fosphenytoin—Cough—Etoposide—peripheral nervous system neoplasm	0.000229	0.000564	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000229	0.000564	CcSEcCtD
Fosphenytoin—Headache—Topotecan—peripheral nervous system neoplasm	0.000229	0.000564	CcSEcCtD
Fosphenytoin—Rash—Tretinoin—peripheral nervous system neoplasm	0.000229	0.000563	CcSEcCtD
Fosphenytoin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000229	0.000563	CcSEcCtD
Fosphenytoin—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000228	0.000562	CcSEcCtD
Fosphenytoin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000228	0.000562	CcSEcCtD
Fosphenytoin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000228	0.000562	CcSEcCtD
Fosphenytoin—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000228	0.00056	CcSEcCtD
Fosphenytoin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000227	0.00056	CcSEcCtD
Fosphenytoin—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000227	0.00056	CcSEcCtD
Fosphenytoin—Headache—Tretinoin—peripheral nervous system neoplasm	0.000227	0.000559	CcSEcCtD
Fosphenytoin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000227	0.000559	CcSEcCtD
Fosphenytoin—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000227	0.000558	CcSEcCtD
Fosphenytoin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000226	0.000557	CcSEcCtD
Fosphenytoin—Constipation—Vincristine—peripheral nervous system neoplasm	0.000226	0.000557	CcSEcCtD
Fosphenytoin—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000557	CcSEcCtD
Fosphenytoin—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000557	CcSEcCtD
Fosphenytoin—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000557	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000226	0.000557	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000556	CcSEcCtD
Fosphenytoin—Rash—Melphalan—peripheral nervous system neoplasm	0.000226	0.000555	CcSEcCtD
Fosphenytoin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000225	0.000555	CcSEcCtD
Fosphenytoin—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000223	0.00055	CcSEcCtD
Fosphenytoin—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000223	0.000549	CcSEcCtD
Fosphenytoin—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000548	CcSEcCtD
Fosphenytoin—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000548	CcSEcCtD
Fosphenytoin—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000548	CcSEcCtD
Fosphenytoin—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000221	0.000544	CcSEcCtD
Fosphenytoin—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000219	0.000538	CcSEcCtD
Fosphenytoin—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000538	CcSEcCtD
Fosphenytoin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000218	0.000537	CcSEcCtD
Fosphenytoin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000217	0.000535	CcSEcCtD
Fosphenytoin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000217	0.000534	CcSEcCtD
Fosphenytoin—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000533	CcSEcCtD
Fosphenytoin—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000216	0.000532	CcSEcCtD
Fosphenytoin—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000531	CcSEcCtD
Fosphenytoin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000215	0.00053	CcSEcCtD
Fosphenytoin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000215	0.00053	CcSEcCtD
Fosphenytoin—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.00053	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000214	0.000528	CcSEcCtD
Fosphenytoin—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000528	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000213	0.000525	CcSEcCtD
Fosphenytoin—Infection—Etoposide—peripheral nervous system neoplasm	0.000213	0.000524	CcSEcCtD
Fosphenytoin—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000524	CcSEcCtD
Fosphenytoin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000213	0.000523	CcSEcCtD
Fosphenytoin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000212	0.000523	CcSEcCtD
Fosphenytoin—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000211	0.00052	CcSEcCtD
Fosphenytoin—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000211	0.00052	CcSEcCtD
Fosphenytoin—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000211	0.00052	CcSEcCtD
Fosphenytoin—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000518	CcSEcCtD
Fosphenytoin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00021	0.000517	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00021	0.000517	CcSEcCtD
Fosphenytoin—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000209	0.000515	CcSEcCtD
Fosphenytoin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000209	0.000515	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000514	CcSEcCtD
Fosphenytoin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000209	0.000514	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000207	0.00051	CcSEcCtD
Fosphenytoin—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000509	CcSEcCtD
Fosphenytoin—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000507	CcSEcCtD
Fosphenytoin—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000204	0.000503	CcSEcCtD
Fosphenytoin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000203	0.000501	CcSEcCtD
Fosphenytoin—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000203	0.0005	CcSEcCtD
Fosphenytoin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000203	0.000499	CcSEcCtD
Fosphenytoin—Hypotension—Etoposide—peripheral nervous system neoplasm	0.0002	0.000493	CcSEcCtD
Fosphenytoin—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000493	CcSEcCtD
Fosphenytoin—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000491	CcSEcCtD
Fosphenytoin—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000487	CcSEcCtD
Fosphenytoin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000197	0.000485	CcSEcCtD
Fosphenytoin—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000481	CcSEcCtD
Fosphenytoin—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000481	CcSEcCtD
Fosphenytoin—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000481	CcSEcCtD
Fosphenytoin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000194	0.000478	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000475	CcSEcCtD
Fosphenytoin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000193	0.000475	CcSEcCtD
Fosphenytoin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000193	0.000474	CcSEcCtD
Fosphenytoin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000191	0.000471	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000469	CcSEcCtD
Fosphenytoin—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000191	0.000469	CcSEcCtD
Fosphenytoin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00019	0.000468	CcSEcCtD
Fosphenytoin—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000467	CcSEcCtD
Fosphenytoin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000188	0.000464	CcSEcCtD
Fosphenytoin—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000463	CcSEcCtD
Fosphenytoin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000188	0.000463	CcSEcCtD
Fosphenytoin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000187	0.00046	CcSEcCtD
Fosphenytoin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000186	0.000459	CcSEcCtD
Fosphenytoin—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000456	CcSEcCtD
Fosphenytoin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000185	0.000455	CcSEcCtD
Fosphenytoin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000183	0.000451	CcSEcCtD
Fosphenytoin—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000451	CcSEcCtD
Fosphenytoin—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.00045	CcSEcCtD
Fosphenytoin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000182	0.000447	CcSEcCtD
Fosphenytoin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000181	0.000446	CcSEcCtD
Fosphenytoin—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000445	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000439	CcSEcCtD
Fosphenytoin—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000438	CcSEcCtD
Fosphenytoin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000435	CcSEcCtD
Fosphenytoin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000177	0.000435	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000434	CcSEcCtD
Fosphenytoin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000176	0.000433	CcSEcCtD
Fosphenytoin—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000432	CcSEcCtD
Fosphenytoin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000175	0.000431	CcSEcCtD
Fosphenytoin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000175	0.00043	CcSEcCtD
Fosphenytoin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000173	0.000426	CcSEcCtD
Fosphenytoin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000173	0.000426	CcSEcCtD
Fosphenytoin—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000424	CcSEcCtD
Fosphenytoin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000172	0.000424	CcSEcCtD
Fosphenytoin—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000422	CcSEcCtD
Fosphenytoin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00017	0.000419	CcSEcCtD
Fosphenytoin—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000418	CcSEcCtD
Fosphenytoin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000169	0.000417	CcSEcCtD
Fosphenytoin—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000417	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000414	CcSEcCtD
Fosphenytoin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000168	0.000414	CcSEcCtD
Fosphenytoin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000168	0.000413	CcSEcCtD
Fosphenytoin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000413	CcSEcCtD
Fosphenytoin—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000412	CcSEcCtD
Fosphenytoin—Rash—Vincristine—peripheral nervous system neoplasm	0.000167	0.000411	CcSEcCtD
Fosphenytoin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000167	0.00041	CcSEcCtD
Fosphenytoin—Headache—Vincristine—peripheral nervous system neoplasm	0.000166	0.000408	CcSEcCtD
Fosphenytoin—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000405	CcSEcCtD
Fosphenytoin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000403	CcSEcCtD
Fosphenytoin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000163	0.000402	CcSEcCtD
Fosphenytoin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00016	0.000394	CcSEcCtD
Fosphenytoin—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000392	CcSEcCtD
Fosphenytoin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000388	CcSEcCtD
Fosphenytoin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000157	0.000387	CcSEcCtD
Fosphenytoin—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000386	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000383	CcSEcCtD
Fosphenytoin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000382	CcSEcCtD
Fosphenytoin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000154	0.000379	CcSEcCtD
Fosphenytoin—Chills—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000374	CcSEcCtD
Fosphenytoin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000152	0.000373	CcSEcCtD
Fosphenytoin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000149	0.000366	CcSEcCtD
Fosphenytoin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000148	0.000363	CcSEcCtD
Fosphenytoin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000147	0.000363	CcSEcCtD
Fosphenytoin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000147	0.000361	CcSEcCtD
Fosphenytoin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000359	CcSEcCtD
Fosphenytoin—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000357	CcSEcCtD
Fosphenytoin—Tension—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000356	CcSEcCtD
Fosphenytoin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000355	CcSEcCtD
Fosphenytoin—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000352	CcSEcCtD
Fosphenytoin—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000351	CcSEcCtD
Fosphenytoin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000142	0.000349	CcSEcCtD
Fosphenytoin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000349	CcSEcCtD
Fosphenytoin—Chills—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000346	CcSEcCtD
Fosphenytoin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000139	0.000342	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000336	CcSEcCtD
Fosphenytoin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000136	0.000336	CcSEcCtD
Fosphenytoin—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000335	CcSEcCtD
Fosphenytoin—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000333	CcSEcCtD
Fosphenytoin—Rash—Etoposide—peripheral nervous system neoplasm	0.000135	0.000333	CcSEcCtD
Fosphenytoin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000135	0.000333	CcSEcCtD
Fosphenytoin—Headache—Etoposide—peripheral nervous system neoplasm	0.000134	0.000331	CcSEcCtD
Fosphenytoin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000331	CcSEcCtD
Fosphenytoin—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000329	CcSEcCtD
Fosphenytoin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000329	CcSEcCtD
Fosphenytoin—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000327	CcSEcCtD
Fosphenytoin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000326	CcSEcCtD
Fosphenytoin—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000326	CcSEcCtD
Fosphenytoin—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000325	CcSEcCtD
Fosphenytoin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000325	CcSEcCtD
Fosphenytoin—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000324	CcSEcCtD
Fosphenytoin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000323	CcSEcCtD
Fosphenytoin—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00013	0.00032	CcSEcCtD
Fosphenytoin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000319	CcSEcCtD
Fosphenytoin—Cough—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000316	CcSEcCtD
Fosphenytoin—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000314	CcSEcCtD
Fosphenytoin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000127	0.000314	CcSEcCtD
Fosphenytoin—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000313	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000311	CcSEcCtD
Fosphenytoin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.00031	CcSEcCtD
Fosphenytoin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000309	CcSEcCtD
Fosphenytoin—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000309	CcSEcCtD
Fosphenytoin—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000308	CcSEcCtD
Fosphenytoin—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000305	CcSEcCtD
Fosphenytoin—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000303	CcSEcCtD
Fosphenytoin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000302	CcSEcCtD
Fosphenytoin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000301	CcSEcCtD
Fosphenytoin—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000301	CcSEcCtD
Fosphenytoin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.0003	CcSEcCtD
Fosphenytoin—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000298	CcSEcCtD
Fosphenytoin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000296	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000296	CcSEcCtD
Fosphenytoin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000295	CcSEcCtD
Fosphenytoin—Infection—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000294	CcSEcCtD
Fosphenytoin—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000293	CcSEcCtD
Fosphenytoin—Shock—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000291	CcSEcCtD
Fosphenytoin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000291	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000118	0.00029	CcSEcCtD
Fosphenytoin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.00029	CcSEcCtD
Fosphenytoin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000289	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000286	CcSEcCtD
Fosphenytoin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000286	CcSEcCtD
Fosphenytoin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000286	CcSEcCtD
Fosphenytoin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000282	CcSEcCtD
Fosphenytoin—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000282	CcSEcCtD
Fosphenytoin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000279	CcSEcCtD
Fosphenytoin—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000276	CcSEcCtD
Fosphenytoin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000276	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000274	CcSEcCtD
Fosphenytoin—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000272	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000109	0.00027	CcSEcCtD
Fosphenytoin—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000269	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000268	CcSEcCtD
Fosphenytoin—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000268	CcSEcCtD
Fosphenytoin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000267	CcSEcCtD
Fosphenytoin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000266	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000265	CcSEcCtD
Fosphenytoin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000264	CcSEcCtD
Fosphenytoin—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000263	CcSEcCtD
Fosphenytoin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000261	CcSEcCtD
Fosphenytoin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000106	0.00026	CcSEcCtD
Fosphenytoin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000257	CcSEcCtD
Fosphenytoin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000256	CcSEcCtD
Fosphenytoin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000253	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000249	CcSEcCtD
Fosphenytoin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000248	CcSEcCtD
Fosphenytoin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	9.99e-05	0.000246	CcSEcCtD
Fosphenytoin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	9.91e-05	0.000244	CcSEcCtD
Fosphenytoin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	9.9e-05	0.000244	CcSEcCtD
Fosphenytoin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	9.89e-05	0.000243	CcSEcCtD
Fosphenytoin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	9.79e-05	0.000241	CcSEcCtD
Fosphenytoin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	9.67e-05	0.000238	CcSEcCtD
Fosphenytoin—Urticaria—Epirubicin—peripheral nervous system neoplasm	9.55e-05	0.000235	CcSEcCtD
Fosphenytoin—Constipation—Doxorubicin—peripheral nervous system neoplasm	9.51e-05	0.000234	CcSEcCtD
Fosphenytoin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	9.5e-05	0.000234	CcSEcCtD
Fosphenytoin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	9.16e-05	0.000226	CcSEcCtD
Fosphenytoin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	8.83e-05	0.000218	CcSEcCtD
Fosphenytoin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	8.79e-05	0.000216	CcSEcCtD
Fosphenytoin—Asthenia—Epirubicin—peripheral nervous system neoplasm	8.62e-05	0.000212	CcSEcCtD
Fosphenytoin—Pruritus—Epirubicin—peripheral nervous system neoplasm	8.5e-05	0.000209	CcSEcCtD
Fosphenytoin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	8.22e-05	0.000202	CcSEcCtD
Fosphenytoin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	7.98e-05	0.000196	CcSEcCtD
Fosphenytoin—Dizziness—Epirubicin—peripheral nervous system neoplasm	7.95e-05	0.000196	CcSEcCtD
Fosphenytoin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	7.87e-05	0.000194	CcSEcCtD
Fosphenytoin—Vomiting—Epirubicin—peripheral nervous system neoplasm	7.64e-05	0.000188	CcSEcCtD
Fosphenytoin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	7.61e-05	0.000187	CcSEcCtD
Fosphenytoin—Rash—Epirubicin—peripheral nervous system neoplasm	7.58e-05	0.000187	CcSEcCtD
Fosphenytoin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	7.57e-05	0.000186	CcSEcCtD
Fosphenytoin—Headache—Epirubicin—peripheral nervous system neoplasm	7.53e-05	0.000185	CcSEcCtD
Fosphenytoin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.35e-05	0.000181	CcSEcCtD
Fosphenytoin—Nausea—Epirubicin—peripheral nervous system neoplasm	7.14e-05	0.000176	CcSEcCtD
Fosphenytoin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	7.07e-05	0.000174	CcSEcCtD
Fosphenytoin—Rash—Doxorubicin—peripheral nervous system neoplasm	7.01e-05	0.000173	CcSEcCtD
Fosphenytoin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7e-05	0.000172	CcSEcCtD
Fosphenytoin—Headache—Doxorubicin—peripheral nervous system neoplasm	6.97e-05	0.000172	CcSEcCtD
Fosphenytoin—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.61e-05	0.000163	CcSEcCtD
